Senti Biosciences Holdings Inc (SNTI) - News Archive

The landscape of cancer treatment is undergoing a transformative evolution as innovative therapies harness the immune system s capabilities. With an increasing emphasis on personalized medicine and cellular therapies, S...

Senti Biosciences Announces Employee Inducement Grants Amid Strategic RestructuringIn a move aimed at bolstering its workforce, Senti Biosciences, Inc. (Nasdaq: SNTI), a pioneering clinical-stage biotechnology firm, has...

Senti Bio Announces Reverse Stock Split: Shares Expected to Begin Trading on Split-Adjusted Basis on July 18, 2024Senti Bio, a leading biotechnology company, made an exciting announcement today regarding their upcoming...

In a groundbreaking move for the field of regenerative medicine, the California Institute for Regenerative Medicines (CIRM) has announced an $8 million grant to Senti Bio. The generous funding is intended to support the...

CSIMarket.com aims to provide a comprehensive overview of the latest advancements in the field of pharmaceutical research and development. In accordance with this , this article sheds light on a groundbreaking developme...

In recent news, Senti Biosciences, Inc. (Nasdaq: SNTI), a specialized bioengineering company, shared its recent corporate and operational updates along with its fiscal first-quarter 2024 financial results, culminating a...

In recent years, significant advancements have been made in the field of cancer therapies, particularly in the realm of cellular immunotherapy. Senti Bio, a leading biotechnology company, has recently released preclinic...

Senti Bio, the synthetic biology company pioneering the design and development of gene circuits, has recently received clearance for its Initial New Drug (IND) application from the Food and Drug Administration (FDA). Th...